Literature DB >> 12111847

Interleukin-4, interleukin-10, and interleukin-1-receptor antagonist but not transforming growth factor-beta induce ramification and reduce adhesion molecule expression of rat microglial cells.

Florentina Wirjatijasa1, Faramarz Dehghani, Roman A Blaheta, Horst-Werner Korf, Nils P Hailer.   

Abstract

The activity of microglial cells is strictly controlled in order to maintain central nervous system (CNS) immune privilege. We hypothesized that several immunomodulatory factors present in the CNS parenchyma, i.e., the Th2-derived cytokines interleukin (IL)-4 and IL-10, interleukin-1-receptor-antagonist (IL-1-ra), or transforming growth factor (TGF)-beta can modulate microglial morphology and functions. Microglial cells were incubated with IL-4, IL-10, IL-1-ra, TGF-beta, or with astrocyte conditioned media (ACM) and were analyzed for morphological changes, expression of intercellular adhesion molecule (ICAM)-1, and secretion of IL-1beta or tumor necrosis factor (TNF)-alpha. Whereas untreated controls showed an amoeboid morphology both Th2-derived cytokines, IL-1-ra, and ACM induced a morphological transformation to the ramified phenotype. In contrast, TGF-beta-treated microglial cells showed an amoeboid morphology. Even combined with the neutralizing antibodies against IL-4, IL-10, or TGF-beta ACM induced microglial ramification. Furthermore, ACM did not contain relevant amounts of IL-4 and IL-10, as measured by enzyme-linked immunosorbent assay (ELISA). Flow cytometry showed that lipopolysaccharide (LPS)-induced ICAM-1-expression on microglial cells was strongly suppressed by ACM, significantly modulated by IL-4, IL-10, or IL-1-ra, but not influenced by TGF-beta. The LPS-induced secretion of IL-1beta and TNF-alpha was only reduced after application of ACM, whereas IL-4 or IL-10 did not inhibit IL-1beta- or TNF-alpha secretion. TGF-beta enhanced IL-1beta- but not TNF-alpha secretion. In summary, we demonstrate that IL-4, IL-10, and IL-1-ra induce microglial ramification and reduce ICAM-1-expression, whereas the secretion of proinflammatory cytokines is not prevented. TGF-beta has no modulating effects. Importantly, unidentified astrocytic factors that are not identical with IL-4, IL-10, or TGF-beta possess strong immunomodulatory properties. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12111847     DOI: 10.1002/jnr.10254

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  15 in total

1.  Astrocyte and macrophage regulation of YKL-40 expression and cellular response in neuroinflammation.

Authors:  Dafna Bonneh-Barkay; Stephanie J Bissel; Julia Kofler; Adam Starkey; Guoji Wang; Clayton A Wiley
Journal:  Brain Pathol       Date:  2011-12-22       Impact factor: 6.508

2.  The impact of glial activation in the aging brain.

Authors:  Aileen M Lynch; Kevin J Murphy; Brian F Deighan; Julie-Ann O'Reilly; Yuri K Gun'ko; Thelma R Cowley; Rodrigo E Gonzalez-Reyes; Marina A Lynch
Journal:  Aging Dis       Date:  2010-09-04       Impact factor: 6.745

Review 3.  T-cell cytokines in injury-induced neural damage and repair.

Authors:  Michael Schroeter; Sebastian Jander
Journal:  Neuromolecular Med       Date:  2005       Impact factor: 3.843

4.  Increased brain injury and worsened neurological outcome in interleukin-4 knockout mice after transient focal cerebral ischemia.

Authors:  Xiaoxing Xiong; George E Barreto; Lijun Xu; Yi Bing Ouyang; Xinmin Xie; Rona G Giffard
Journal:  Stroke       Date:  2011-05-19       Impact factor: 7.914

Review 5.  Role of cytokines as mediators and regulators of microglial activity in inflammatory demyelination of the CNS.

Authors:  Tobias D Merson; Michele D Binder; Trevor J Kilpatrick
Journal:  Neuromolecular Med       Date:  2010-03-30       Impact factor: 3.843

6.  Treatment in vitro of retinal cells with IL-4 increases the survival of retinal ganglion cells: the involvement of BDNF.

Authors:  Leandro de Araujo-Martins; Raphael Monteiro de Oliveira; Gabriela Velozo Gomes dos Santos; Renata Cláudia Celestino dos Santos; Aline Araujo dos Santos; Elizabeth Giestal de Araujo
Journal:  Neurochem Res       Date:  2012-10-16       Impact factor: 3.996

7.  Human interleukin-10 gene transfer is protective in a rat model of Parkinson's disease.

Authors:  Louisa C Johnston; Xiaomin Su; Kathleen Maguire-Zeiss; Karen Horovitz; Irina Ankoudinova; Dmitry Guschin; Piotr Hadaczek; Howard J Federoff; Krystof Bankiewicz; John Forsayeth
Journal:  Mol Ther       Date:  2008-06-10       Impact factor: 11.454

8.  Reducing inflammation through delivery of lentivirus encoding for anti-inflammatory cytokines attenuates neuropathic pain after spinal cord injury.

Authors:  Jonghyuck Park; Joseph T Decker; Dominique R Smith; Brian J Cummings; Aileen J Anderson; Lonnie D Shea
Journal:  J Control Release       Date:  2018-10-06       Impact factor: 9.776

Review 9.  Potential of immunosuppressive agents in cerebral ischaemia.

Authors:  Yogendra Kumar Gupta; Anjali Chauhan
Journal:  Indian J Med Res       Date:  2011-01       Impact factor: 2.375

10.  The microglial activation state regulates migration and roles of matrix-dissolving enzymes for invasion.

Authors:  Starlee Lively; Lyanne C Schlichter
Journal:  J Neuroinflammation       Date:  2013-06-21       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.